EUCOPE’s latest position paper outlines our vision for the evolution of the EU Regulatory framework and a modernisation of the Centralised Procedure to ultimately bring novel medicines earlier to patients. The European Centralised Procedure (CP) has helped and accelerated the approval of novel medicines across… read more
Joint Clinical Assessments Will Become A Key Part Of The New Environment Regulation (EU) 2021/2282 on health technology assessment (HTA) is now in force and will bring important and wide-reaching changes that pharmaceutical companies need to understand. Arguably the most important implication of the regulation… read more
As the EU trade body for small to mid-sized companies that support, invest and produce the innovative medicines and therapies of the future, EUCOPE is happy to welcome five new members to its organisation. AOP Health, Enterome, Flatiron Health, Novo Nordisk and TETEC all became… read more
The multi-stakeholder European Expert Group on Orphan Drug Incentives (OD Expert Group) has officially announced the kick-off of Phase 2 of its work on 29 March, during the DIA Europe session on “The European Expert Group on Orphan Drug Incentives: a Blueprint for Health and… read more
EUCOPE is growing and we’re looking to recruit a talented Policy Officer with a sound knowledge of the EU institutions, its processes and policies. About you You are educated to degree level in a relevant field and have gathered first public affairs experiences from working… read more
In the March 2022 edition of The European Files, Alexander Natz wrote about the need for a flexible legislative framework to promote European competitiveness on a global stage. Europe is home to a rich innovation ecosystem with start-ups, world-class research institutions, top universities for life… read more
Every month, EUCOPE spotlights a member company and the great work they’re doing to advance the life sciences industry and drive innovation to serve patients better. In February, we spoke with Jan G. Smith, CEO of Circius Pharma. Jan has over 40 years of experience… read more
Every month, EUCOPE spotlights a member company and the great work they’re doing to drive healthcare innovation in Europe to serve patients better. In February, we spoke with Peter Martin, Director of Norgine BV. Peter Martin has worked in the pharmaceutical industry in Europe and… read more
On our latest Sounds of Science Podcast, we discuss upcoming developments in the field of rare diseases, a timely matter as Rare Disease Day approaches on 28 February. Rare disease is a topic which is very close to the heart of our organisation, as almost… read more
EUCOPE’s Alexander Natz discusses the need for a holistic, integrated, and well-functioning EU environment to foster innovation and re-invest in R&D during the EURONEWS Debates. Rare diseases pose a significant challenge to the European health institutions. Due to the relative irregularity that people suffer from… read more
Keep up-to-date on all of the most pertinent policy files and regulatory news around the world of European health technologies with our monthly newsletter – the Innovation Eye-View